EPE Special Opps Ltd - Result of AGM and Issue of Shares
RNS Number : 8332Q
EPE Special Opportunities Limited
23 June 2020

EPE Special Opportunities Limited


Result of Annual General Meeting and Issue of Shares



Result of Annual General Meeting


EPE Special Opportunities Limited (the "Company") is pleased to announce that at its Annual General Meeting, held today, all resolutions proposed were passed.



Issue of Shares


The Company announces that applications have been made to the and Aquis Stock Exchange for a listing of 77,493 ordinary shares of £0.05 each in the Company (the "Ordinary Shares") to be admitted to trading on the AIM market and the AQSE Growth Market ("Admission"). Admission is expected to take place on 26 June 2020. The Ordinary Shares are to be issued to satisfy the obligations of a group undertaking.


The Ordinary Shares will, upon issue, be fully paid and rank pari passu in all respects with the Company's existing issued ordinary shares.


The number of Ordinary Shares in issue, not held by the Company in treasury, following the transaction and the figure to be used as the denominator for calculations of interests in the Company's voting rights is 32,948,303 Ordinary Shares. The number of Ordinary Shares held by the Company in treasury following the transaction is 1,668,251 Ordinary Shares.



The person responsible for releasing this information on behalf of the Company is Amanda Robinson of Langham Hall Fund Management (Jersey) Limited.




EPIC Private Equity LLP

+44 (0) 207 269 8865

Alex Leslie

Langham Hall Fund Management (Jersey) Limited

+44 (0) 153 488 5200

Amanda Robinson

Cardew Group Limited

+44 (0) 207 930 0777

Richard Spiegelberg

Numis Securities Limited

+44 (0) 207 260 1000

Nominated Advisor:

Stuart Skinner / Hugh Jonathan

Corporate Broker:

Charles Farquhar



This information is provided by RNS, the news service of the . RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.